x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

OncoPharm

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

science

All Episodes

00:15:18

Updated Adjuvant Atezolizumab Data (& more)

OncoPharm ·

2022/08/11

New OS data is out for adjuvant atezolizumab in NSCLC - how does it compare to the original DFS data? Plus, lots of recent FDA expanded approvals to discuss.

en

00:14:16

The Infamous Erlotinib Study

OncoPharm ·

2022/08/04

An infamous study that led to a drug approval of limited benefit, but still made its way into an episode of Better Call Saul. Erlotinib + gemcitabine vs. gemcitabine: https://doi.org/10.1200/jco.2006.07.9525

en

00:21:04

Long Term Follow-Up

OncoPharm ·

2022/07/28

Several recent large trials just released long term follow-up results on overall survival. We look at what how treatment principles may change based on these mature data. ECHELON-1 - Hodgkin's (A+AVD vs. ABVD) POLO - Pancreatic (olaparib maintenance vs. placebo) Keynote 355 - mTNBC (pembrolizumab + chemo vs. chemo) APHinity - adjuvant HER+ breast (pertuzumab/trastuzumab vs. trastuzumab) E1912 - CLL (ibrutinib/rituximab vs. FCR)

en

00:20:42

Living With Lupus

OncoPharm ·

2022/07/14

Discussion with a Lupus Nephritis patient (and Pharm.D. student) about manifestations and treatments of SLE and Lupus Nephritis.

en

00:17:05

ICIs & PPIs - Something to Worry About?

OncoPharm ·

2022/07/07

Sifting through and summarizing lots of data on concomitant use of ICIs and PPIs. Suggested readings: 1. All the drugs: https://pubmed.ncbi.nlm.nih.gov/33154150/ 2. Pooled atezolizumab study: https://pubmed.ncbi.nlm.nih.gov/35183773/ 3. Clostridium butyricum may be a thing: https://pubmed.ncbi.nlm.nih.gov/35655708/ 4. AKI risk: https://doi.org/10.21873/invivo.12570 5. Is this all noise?: https://pubmed.ncbi.nlm.nih.gov/35280736/ 6. Abx & PPIs: https://doi.org/10.3389/fimmu.2021.716317

en

00:10:04

APAP + ICI: An emerging concern?

OncoPharm ·

2022/06/30

Acetaminophen (or paracetamol) & immune checkpoint inhibitors are ubiquitous in oncology practices. So, when new translational research suggests APAP may decrease the effectiveness - well that seems like something worth talking about. Impact of acetaminophen on the efficacy of immunotherapy in cancer patients: https://doi.org/10.1016/j.annonc.2022.05.010 Hepatotoxicity risk factors with ICIs: https://doi.org/10.1097/cji.0000000000000347

en

00:19:52

FN Updates

OncoPharm ·

2022/06/23

Febrile neutropenia updates on... Short duration antibiotics: https://doi.org/10.1016/S2352-3026(22)00145-4 Same-day pegfilgrastim: https://doi.org/10.2217/fon-2022-0365

en

00:16:03

LGBTQ Clinical Pearls

OncoPharm ·

2022/06/16

Maya Leiva, PharmD, BCOP joins the Pod once again this Pride month to give us some LGBTQ clinical pearls on carboplatin dosing in trans patients and pregnancy/teratogenicity chemo counseling. LGBT Cancer Network: https://cancer-network.org

en

00:27:43

ASCO 2022 Highlights

OncoPharm ·

2022/06/09

Highlights from ASCO's 2022 annual meeting.

en

00:21:28

Transgender Cancer Screening

OncoPharm ·

2022/06/02

Maya Leiva, PharmD, BCOP joins the Pod for Pride to give an overview of cancer screenings in the transgender population.

en

00:15:42

What's Next In NSCLC & AML?

OncoPharm ·

2022/05/26

Looking at some interesting articles as possible predictors of what to expect next in NSCLC and AML. NADIM: https://pubmed.ncbi.nlm.nih.gov/?term=35576508 Ven + Intensive Chemo: https://doi.org/10.1016/S2352-3026(22)00100-4

en

00:21:15

How To Use Our Favorite Guidelines

OncoPharm ·

2022/05/19

By listener request, we discuss how to utilize our favorite guidelines.

en

00:14:18

Docetaxel

OncoPharm ·

2022/05/12

A Foundation of OncoPharm: Docetaxel

en

00:17:04

Adjuvant HD Cisplatin-RT For High Risk Head & Neck...

OncoPharm ·

2022/05/05

The Landmarks of OncoPharm series returns to discuss 2 landmark studies (and 1 editorial) in head & neck cancer. Editorial: https://ascopubs.org/doi/pdf/10.1200/JCO.22.00274 EUORTC Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032641 Intergroup Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032646

en

00:10:57

Melanoma In A Nutshell

OncoPharm ·

2022/04/28

The highlights, and only the highlights, of melanoma.

en

00:21:38

Loong TFRs In CML, A Lack Of Agility, & CHEKCMATE 816

OncoPharm ·

2022/04/21

Treatment-free remission (TFR) rates in CML of close to 80% have recently been described (https://doi.org/10.1002/ajh.26550). The AGILE study. If you can't say anything nice. Checking back in on CHECKMATE 816 (neoadjuvant Nico-Chemo in NSCLC) and Keynote-177 (pembrolizumab in MSI-H/dMMR colorectal cancer).

en

00:10:42

Ribociclib-Tamoxifen: A Cautionary Tale

OncoPharm ·

2022/04/14

Ribociclib-Tamoxifen: A Cautionary Tale by John Bossaer

en

00:18:11

Relatlimab + Nivo And the VISION trial

OncoPharm ·

2022/04/07

Catching on recent FDA approvals on relatlimab/nivolumab (it's relatLimab not relatimab) as well as Lu-PSMA-177 based on the VISION trial.

en

00:16:58

HOPA Boston Preview

OncoPharm ·

2022/03/28

Open up your Yelp app and check out Leukemia Pharmacist & Boston denizen Jessie Signorelli's recommendations for eating, drinking, & sight seeing in Boston. Also, great educational programming awaits!

en

00:15:56

DESTINY-Breast03

OncoPharm ·

2022/03/24

Trastuzumab deruxtecan vs. trastuzumab trastuzumab

en

423 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter